March 3, 2020 / 3:19 PM / a month ago

BRIEF-Autolus Therapeutics PLC FY Loss Per Share $2.88

March 3 (Reuters) - Autolus Therapeutics PLC:

* AUTOLUS THERAPEUTICS PLC - FY LOSS PER SHARE $2.88

* AUTOLUS THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND OPERATIONAL PROGRESS

* AUTOLUS THERAPEUTICS PLC - ANTICIPATES THAT CASH ON HAND PROVIDES A RUNWAY INTO 2022

* AUTOLUS THERAPEUTICS - AUTO1 IS POISED FOR PHASE 2 CLINICAL TRIAL STARTING FIRST HALF 2020, AUTO3 IS PROGRESSING TO PHASE 2 DECISION POINT IN MID-2020 Source text: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below